Podiatrists in Leavenworth, KS Accepting Medicare
5 Podiatrists found. Showing 1 - 5
 Dr. Golnar Prudhomme, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-758-4177 |
Christiane Helen Gardner, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-758-4177 |
Dr. Dolly Marie Stelzer, DPM Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1001 6th Ave, Suite 340, Leavenworth, KS 66048 Phone: 913-651-7151 |
 Dr. Dan Edward Robinson, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 4101 S 4th Trafficway, 112a, Leavenworth, KS 66048 Phone: 913-682-2000 |
 Comprehensive Foot Centers P.a. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 503 Olive St, Leavenworth, KS 66048 Phone: 816-455-1155 Fax: 816-455-1161 |
News Archive
New, simpler surgical intervention not better than old method for treatment of intestinal perforation
A new and simpler surgical method for the treatment of intestinal perforation is a poorer alternative for patients compared to the old method, researchers at the University of Oslo and Akershus University Hospital find. The study raises important questions about the testing of new surgical methods.
Popular injectable contraceptive increases risk of STD's
The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman's risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive
New tablet fabrication method can make personalized medicine cheaper, easier
A team of researchers from the National University of Singapore have found a way to make personalized medicine cheaper and easier.
Pfenex reports total revenue of $3.3 million for second quarter 2014
Pfenex Inc., a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins including biosimilar therapeutics, today provided a business update and reported financial results for the second quarter ended June 30, 2014.
› Verified 3 days ago
Occupational Therapists
Speech-Language Pathologists
Physical Therapists
Optometrists
Chiropractors
Audiologists
Podiatrists